Literature DB >> 31177244

Predictors of outcomes in exercisers with Parkinson disease: A two-year longitudinal cohort study.

Stephanie A Combs-Miller1, Elizabeth S Moore1.   

Abstract

BACKGROUND: Exercise may modify disease progression in persons with Parkinson disease (PD).
OBJECTIVE: The purpose of this longitudinal cohort study was to determine factors that predict motor, activity, and participation-based outcomes over two years in exercisers with PD.
METHODS: A convenience sample with idiopathic PD was included in the analysis [n = 74; mean age 66.7(8.4) years; male 54%; median months post diagnosis 69.0(76.0), median Hoehn and Yahr score 1.0(2.0)]. Exercise behaviors (minutes of exercise/week, peak rate of perceived exertion (RPE) and mode of exercise) and outcomes of impairment [grip strength], activity [10-meter walk test, functional reach test, activity specific balance confidence scale] and participation [Parkinson Disease Questionnaire-39] were assessed at baseline, 6, 12, 18 and 24 months.
RESULTS: Using generalized estimating equations at least one exercise behavior was a significant predictor across most of the models (p≤0.026), with higher RPE predicting better outcomes in all activity and participation domains. Younger age, male gender and lower disease severity also significantly predicted better outcomes over time (p≤0.041).
CONCLUSIONS: Exercise behaviors contributed to activity and participation-based outcomes over two years in exercisers with PD. Participation in high-intensity exercise programs may enhance maintenance of health and function over time in individuals with PD.

Entities:  

Keywords:  Parkinson disease; boxing; exercise; intensity; participation

Mesh:

Year:  2019        PMID: 31177244     DOI: 10.3233/NRE-182641

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  6 in total

1.  Longitudinal observational study of boxing therapy in Parkinson's disease, including adverse impacts of the COVID-19 lockdown.

Authors:  Craig Horbinski; Katelyn B Zumpf; Kathleen McCortney; Dean Eoannou
Journal:  BMC Neurol       Date:  2021-08-24       Impact factor: 2.474

Review 2.  Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?

Authors:  Grace F Crotty; Michael A Schwarzschild
Journal:  Front Aging Neurosci       Date:  2020-06-19       Impact factor: 5.750

3.  Prediction of Responsiveness of Gait Variables to Rehabilitation Training in Parkinson's Disease.

Authors:  Mariano Serrao; Giorgia Chini; Guido Caramanico; Michelangelo Bartolo; Stefano Filippo Castiglia; Alberto Ranavolo; Carmela Conte; Teresa Venditto; Gianluca Coppola; Cherubino di Lorenzo; Patrizio Cardinali; Francesco Pierelli
Journal:  Front Neurol       Date:  2019-08-02       Impact factor: 4.003

4.  Longitudinal Study of Boxing Therapy in Parkinson's Disease, Including Adverse Impacts of the COVID-19 Lockdown.

Authors:  Craig Horbinski; Katelyn B Zumpf; Kathleen McCortney; Dean Eoannou
Journal:  Res Sq       Date:  2021-04-07

Review 5.  Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes.

Authors:  Ashley Polhemus; Laura Delgado Ortiz; Gavin Brittain; Nikolaos Chynkiamis; Francesca Salis; Heiko Gaßner; Michaela Gross; Cameron Kirk; Rachele Rossanigo; Kristin Taraldsen; Diletta Balta; Sofie Breuls; Sara Buttery; Gabriela Cardenas; Christoph Endress; Julia Gugenhan; Alison Keogh; Felix Kluge; Sarah Koch; M Encarna Micó-Amigo; Corinna Nerz; Chloé Sieber; Parris Williams; Ronny Bergquist; Magda Bosch de Basea; Ellen Buckley; Clint Hansen; A Stefanie Mikolaizak; Lars Schwickert; Kirsty Scott; Sabine Stallforth; Janet van Uem; Beatrix Vereijken; Andrea Cereatti; Heleen Demeyer; Nicholas Hopkinson; Walter Maetzler; Thierry Troosters; Ioannis Vogiatzis; Alison Yarnall; Clemens Becker; Judith Garcia-Aymerich; Letizia Leocani; Claudia Mazzà; Lynn Rochester; Basil Sharrack; Anja Frei; Milo Puhan
Journal:  NPJ Digit Med       Date:  2021-10-14

6.  Boxing vs Sensory Exercise for Parkinson's Disease: A Double-Blinded Randomized Controlled Trial.

Authors:  Kishoree Sangarapillai; Benjamin M Norman; Quincy J Almeida
Journal:  Neurorehabil Neural Repair       Date:  2021-06-13       Impact factor: 3.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.